Albion Financial Group’s Zimmer Biomet ZBH Stock Holding History

Albion Financial Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.75K	Hold	90	–	–	﹤0.01%	452
2026 Q1	$8.14K	Hold	90	–	–	﹤0.01%	432
2025 Q4	$8.09K	Hold	90	–	–	﹤0.01%	428
2025 Q3	$8.87K	Hold	90	–	–	﹤0.01%	403
2025 Q2	$8.21K	Hold	90	–	–	﹤0.01%	379
2025 Q1	$10.2K	Hold	90	–	–	﹤0.01%	372
2024 Q4	$9.51K	Buy	+90	New	+$9.66K	﹤0.01%	405
2022 Q3	–	Sell	-1	Closed	–	–	583
2022 Q2	$0	Hold	1	–	–	﹤0.01%	636
2022 Q1	$0	Sell	1 -1	-50%	-$121	﹤0.01%	679
2021 Q4	$0	Buy	+2	New	+$262	﹤0.01%	701

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Albion Financial Group's ZBH Position: Q2 2026 in Review

Albion Financial Group held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 90 shares worth $7.75K. The position accounts for ﹤0.01% of the portfolio, ranked #452.

Albion Financial Group first reported a position in ZBH in Q4 2021 and has held it in 10 quarters since. The position peaked at $10.2K in Q1 2025. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Albion Financial Group held 90 shares of Zimmer Biomet worth $7.75K as of Q2 2026.
Albion Financial Group left its Zimmer Biomet share count unchanged in Q2 2026.
Zimmer Biomet made up ﹤0.01% of Albion Financial Group's portfolio in Q2 2026, its #452 holding.
Albion Financial Group first reported a position in Zimmer Biomet in Q4 2021 and has held it in 10 quarters since.
Albion Financial Group's Zimmer Biomet position peaked at $10.2K in Q1 2025.
906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Albion Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.